1652 — Fusen Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$802.45m
- HK$1.03bn
- CNY491.76m
- 61
- 35
- 10
- 23
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Short Term Investments | |||||
Cash and Short Term Investments | 561 | 331 | 313 | 81.7 | 133 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 120 | 201 | 240 | 259 | 311 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 884 | 674 | 660 | 509 | 614 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 154 | 379 | 486 | 506 | 530 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,163 | 1,176 | 1,241 | 1,239 | 1,350 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 451 | 461 | 548 | 489 | 722 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 549 | 503 | 582 | 581 | 736 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 614 | 673 | 659 | 658 | 614 |
Total Liabilities & Shareholders' Equity | 1,163 | 1,176 | 1,241 | 1,239 | 1,350 |
Total Common Shares Outstanding |